Ticker ANPC – Anpac Bio Med – sales, description, marketcap – Tickerday.com

ANPC

Anpac Bio Med

–

Index: NASDAQ; Sector: ; Industry: ;

Marketcap: –; Volume: 31.38K; AvgVol 3m: 316.16K; Beta: –;

Cost estimate:

P/E: –; EPS: -0.99; EPS growth quarter/prev quarter: ;

EPS growth this year: -140.30%; EPS growth past 5 years: ;

EPS ttm: -1.00;

P/S: 25.42; P/B: ; P/Cashflow: 48.02; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: 3.40%; Sales growth past 5 years: ;

Profitability:

Gross Margin: 46.10%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: ; Insider Transactions:;

Institutional Ownership: 0.02%; Institutional Transactions: ;

Data update: 07/10/2020.